“Donor And Recipient Plasma Follistatin Levels Are Associated With Acute Gvhd In Blood And Marrow Transplant Clinical Trials Network 0402.”. Bone Marrow Transplant 53 (1). Bone Marrow Transplant: 64-68. doi:10.1038/bmt.2017.236.
. 2018. “Grade Iii - Iv Acute Gvhd And Treatment-Related Mortality Are Reduced Among Recipients Of Larger Numbers Of Donor Naïve Cd8+ T-Cells And Plasmacytoid Dendritic Cell Precursors In Allogeneic Bm Grafts From Unrelated Donors: Results From Bmt Ctn 0201”. In 38Th Annual Ebmt (European Group For Blood And Marrow Transplantation). 38Th Annual Ebmt (European Group For Blood And Marrow Transplantation). Geneva, Switzerland. http://www.congrex.ch/ebmt2012.html.
. 2012. . 2014.
“Recommendations For Donor Human Leukocyte Antigen Assessment And Matching For Allogeneic Stem Cell Transplantation: Consensus Opinion Of The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn)”. Biol Blood Marrow Transplant. Biol Blood Marrow Transplant. http://www.ncbi.nlm.nih.gov/pubmed/25278457.
. 2014.